HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CRN Selects Former CHPA Exec Mister As Next President

This article was originally published in The Tan Sheet

Executive Summary

Steven Mister brings extensive federal and state government affairs experience to his new post as president and CEO of the Council for Responsible Nutrition

You may also be interested in...



CRN appointment

Andrew Shao, PhD, has been appointed VP-scientific & regulatory affairs for the Council for Responsible Nutrition, the association announces April 1. Shao previously served as a senior scientist for GNC, where he reviewed new products and ingredients to determine their scientific viability and applications. John Hathcock, PhD, will continue to serve as VP-scientific & international affairs. The appointment closely follows that of incoming CRN President Steve Mister, who will assume his role later this month (1"The Tan Sheet" March 14, 2005, p. 8)...

Capitol Hill, California Pose More Challenges For Supplement Industry In 2005

The Vioxx recall and other prescription drug crises likely will lead to even more congressional scrutiny of dietary supplements, according to lobbyists working with the industry

Dietary Supplement AER Bill Fails To Pass California Legislature

Supplement manufacturers scored a legislative victory in California when the state Assembly voted against a bill that would have established a mandatory adverse event reporting system

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS126740

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel